Breast Neoplasm Malignant Female Clinical Trial
Official title:
Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in a Celcuity-Sponsored Clinical Study (B2151009)
Continued access to treatment for subjects who continue benefit from therapy with gedatolisib in combination with palbociclib, and fulvestrant or letrozole.
The primary purpose of this study is to provide continuing access to treatment for subjects who continue benefit from therapy with gedatolisib in combination with palbociclib, and fulvestrant or letrozole. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05941299 -
Clinical Trial to Demonstrate the Safety and Performance of REGENERA Breast Implant in 40-70 Years Old Women Affected by Malignant Breast Lesion Treated by Lumpectomy
|
N/A | |
| Completed |
NCT04348955 -
Interest of Touch-massage in Hospital Day Care
|
||
| Completed |
NCT05812326 -
PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04424732 -
SBRT for Breast Cancer Oligometastases
|
N/A | |
| Completed |
NCT03109080 -
Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)
|
Phase 1 | |
| Recruiting |
NCT04198727 -
Study of the Impact of DPD Activity on the Efficacy of Capecitabine
|
N/A | |
| Completed |
NCT03525990 -
Study Evaluating the Impact of Electronic Surveys on Patient-physician Communication and Quality of Life in Breast Cancer Patients
|
N/A | |
| Recruiting |
NCT04289805 -
Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)
|
Phase 4 |